Interaction of 11C-tariquidar and 11C-elacridar with P-glycoprotein and breast cancer resistance protein at the human blood-brain barrier.
about
The multidrug transporter ABCG2: still more questions than answersSmall and Innovative Molecules as New Strategy to Revert MDRSystemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of RodentsRole of (drug) transporters in imaging in health and disease.Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes.CNS uptake of bortezomib is enhanced by P-glycoprotein inhibition: implications for spinal muscular atrophyPilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood-Brain BarrierRole of P-glycoprotein in the distribution of the HIV protease inhibitor atazanavir in the brain and male genital tract.Using positron emission tomography to study transporter-mediated drug-drug interactions in tissues.Drug transporters in the central nervous system.Radiopharmaceuticals for assessing ABC transporters at the blood-brain barrier.Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.Membrane Assays to Characterize Interaction of Drugs with ABCB1.Efflux proteins at the blood-brain barrier: review and bioinformatics analysis.Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET study.Influence of breast cancer resistance protein and P-glycoprotein on tissue distribution and excretion of Ko143 assessed with PET imaging in mice.[MUV researcher of the month, March 2015].Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors.Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration
P2860
Q26747187-91694A29-A683-472D-A633-28E723D139D6Q27012455-3192518D-FCF2-4657-86D3-6266857003E7Q27301271-0ADC99E0-359E-4180-8FE5-C72211B9B316Q30854787-5104C3D0-0928-4A0D-AAD7-56BCB2503CD9Q35768413-B0A1350B-A7CA-4D01-A0A4-79FB9371467AQ36618001-5FDD7DC8-5A12-43BE-B116-B313AF633D38Q37164563-780771C4-C6CD-4834-A670-B7AF01748C53Q37643618-AE4B5B70-35D0-47F3-B6D9-4E982D11505FQ38200490-F021B012-CD18-4815-AF37-565921FC4BF1Q38342677-8E5D7EA3-8BD9-4E87-B722-A2D4BE7D1778Q38351240-816953DB-24ED-45CC-B233-855B9A9FD9C7Q38844653-9EAA4A63-C02E-40F5-8F3E-390D423B1CCBQ38880731-7BA8618C-843E-4DC8-BA52-4F593E407486Q39290800-0C476BC4-716E-47D9-9196-4CF7B71C927CQ40308640-54DCDC5A-1AEF-48F3-A1B9-FA8E39323851Q47845084-529C68FD-D043-4920-A737-89163FCE5A75Q52710136-A1F8D497-45CD-4403-9D04-0AA4BEA06854Q52908251-F1676F4C-F0F3-4EF8-ADA0-2C16348E5194Q57137963-BF0E3AC8-6A19-418B-8B7D-CC3FDB4EDE73
P2860
Interaction of 11C-tariquidar and 11C-elacridar with P-glycoprotein and breast cancer resistance protein at the human blood-brain barrier.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Interaction of 11C-tariquidar ...... the human blood-brain barrier.
@en
type
label
Interaction of 11C-tariquidar ...... the human blood-brain barrier.
@en
prefLabel
Interaction of 11C-tariquidar ...... the human blood-brain barrier.
@en
P2093
P2860
P50
P1476
Interaction of 11C-tariquidar ...... the human blood-brain barrier.
@en
P2093
Johann Stanek
Markus Müller
Markus Zeitlinger
Rudolf Karch
P2860
P304
P356
10.2967/JNUMED.112.118232
P407
P50
P577
2013-07-05T00:00:00Z